These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2433306)

  • 21. Schwann cell remyelination and recurrent demyelination in the central nervous system of mice infected with attenuated Theiler's virus.
    Dal Canto MC; Lipton HL
    Am J Pathol; 1980 Jan; 98(1):101-22. PubMed ID: 7350812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theiler's murine encephalomyelitis virus induces tumour necrosis factor-alpha in murine astrocyte cell cultures.
    Sierra A; Rubio N
    Immunology; 1993 Mar; 78(3):399-404. PubMed ID: 8478023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.
    Fujinami RS; Rosenthal A; Lampert PW; Zurbriggen A; Yamada M
    J Virol; 1989 May; 63(5):2081-7. PubMed ID: 2539504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus.
    Dal Canto MC; Lipton HL
    J Neurol Sci; 1979 Aug; 42(3):391-405. PubMed ID: 512673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler's murine encephalomyelitus virus.
    Kim BS; Choe YK; Crane MA; Jue CR
    Immunol Lett; 1992 Feb; 31(2):199-205. PubMed ID: 1371268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment.
    Friedmann A; Frankel G; Lorch Y; Steinman L
    J Virol; 1987 Mar; 61(3):898-903. PubMed ID: 3492612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis.
    Lindsley MD; Patick AK; Prayoonwiwat N; Rodriguez M
    Mayo Clin Proc; 1992 Sep; 67(9):829-38. PubMed ID: 1434926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection.
    Dal Canto MC; Lipton HL
    Am J Pathol; 1982 Jan; 106(1):20-9. PubMed ID: 6275708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.
    Rodriguez M; Dunkel AJ; Thiemann RL; Leibowitz J; Zijlstra M; Jaenisch R
    J Immunol; 1993 Jul; 151(1):266-76. PubMed ID: 8326128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus.
    Paya CV; Patick AK; Leibson PJ; Rodriguez M
    J Immunol; 1989 Jul; 143(1):95-102. PubMed ID: 2543704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation.
    Borrow P; Nash AA
    Immunology; 1992 May; 76(1):133-9. PubMed ID: 1628891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus.
    Altintas A; Cai Z; Pease LR; Rodriguez M
    J Immunol; 1993 Sep; 151(5):2803-12. PubMed ID: 8360494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene.
    Rodriguez M; Kenny JJ; Thiemann RL; Woloschak GE
    Microb Pathog; 1990 Jan; 8(1):23-35. PubMed ID: 2333032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of Theiler's virus-induced demyelination in nude mice.
    Rosenthal A; Fujinami RS; Lampert PW
    Lab Invest; 1986 May; 54(5):515-22. PubMed ID: 3517486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.
    Nitayaphan S; Toth MM; Roos RP
    J Virol; 1985 Feb; 53(2):651-7. PubMed ID: 2578578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theiler's murine encephalomyelitis virus--characterization of newly isolated viruses from Japanese mouse colonies.
    Miyata H; Sato H
    Jikken Dobutsu; 1990 Oct; 39(4):539-48. PubMed ID: 2242766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of immunization with Theiler's virus on the course of demyelinating disease.
    Crane MA; Yauch R; Dal Canto MC; Kim BS
    J Neuroimmunol; 1993 Jun; 45(1-2):67-73. PubMed ID: 8331166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size.
    Lipton HL
    J Gen Virol; 1980 Jan; 46(1):169-77. PubMed ID: 6243340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody to myelin-associated glycoprotein reacts with plasma cells in mice.
    Dal Canto MC; Barbano RL
    J Neuroimmunol; 1986 Jan; 10(3):279-86. PubMed ID: 2416774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.
    Brokstad KA; Page M; Nyland H; Haaheim LR
    Acta Neurol Scand; 1994 Jun; 89(6):407-11. PubMed ID: 7526591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.